Triple-B Study;Carboplatin-cyclophosphamide Versus Paclitaxel With or Without Atezolizumab as First-line Treatment in Advanced Triple Negative Breast Cancer
Clinical trial NCT01898117 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT01898117
- Sponsor
- The Netherlands Cancer Institute
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-07-01
- Primary completion
- 2024-04-01
- Enrollment
- 304
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.